|
業務類別
|
Biotechnology |
|
業務概覽
|
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD). |
| 公司地址
| 10240 Sorrento Valley Road, Suite 300, San Diego, CA, USA, 92121 |
| 電話號碼
| +1 858 731-8389 |
| 傳真號碼
| +1 858 731-8394 |
| 公司網頁
| https://www.atyrpharma.com |
| 員工數量
| 58 |
| Dr. Sanjay S. Shukla, M.D.,M.S. |
Director, President and Chief Executive Officer |
美元 638.98K |
26/03/2026 |
| Ms. Jill M. Broadfoot |
Chief Financial Officer and Principal Accounting Officer |
美元 471.79K |
26/03/2026 |
| Ms. Nancy E. Denyes |
General Counsel and Corporate Secretary |
美元 451.57K |
26/03/2026 |
|
|
| Dr. Svetlana Lucas, PhD |
Independent Director |
26/03/2026 |
| Dr. Jane A. Gross, PhD |
Independent Director |
26/03/2026 |
| Dr. Sanjay S. Shukla, M.D.,M.S. |
Director, President and Chief Executive Officer |
26/03/2026 |
| Dr. Sara L. Zaknoen, M.D. |
Independent Director |
26/03/2026 |
| Mr. Timothy P. Coughlin |
Chairman of the Board |
26/03/2026 |
| Dr. Paul R. Schimmel,PhD |
Independent Director |
26/03/2026 |
| Mr. Eric S. Benevich |
Independent Director |
26/03/2026 |
|
|
|
|
